General Dynamics Information Technology has won the Omnibus IV Medical Research and Development contract by the Defense Health Agency.
This multiple-award indefinite delivery, indefinite quantity contract has a total ceiling of $10 billion with a 5-year base period and one 5-year option.
The Defense Department uses Omnibus contracting vehicles for discovery and evaluation of innovative medical solutions and supports DHA’s medical research and development initiatives.
“GDIT has partnered with the Military Health System for more than 30 years. We are honored to support our nation’s service members and their families with advanced medical research and technical expertise that will enhance their health and safety,” said Kamal Narang, GDIT vice president and general manager for federal health.
GDIT was awarded a position to compete for task orders in all four market segments: research and development; research and development support services; regulatory processes; and translational science support and services.
These four market segments encompass a broad range of program areas, including medical simulation technologies; infectious diseases; military health, performance, and recovery; clinical and rehabilitative medicine; and emerging science and technology.
